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ABSTRACT
Sleep Patterns and Associated Factors in Children and Adolescents with
Inflammatory Bowel Disease
Margo M. Szabo, M.S.
Youth with inflammatory bowel disease (IBD) may be at increased risk for sleep difficulties due to
the inflammatory nature of their disease. Moreover, previous research has demonstrated that
children and adolescents with IBD experience impairment across a variety of psychosocial
domains. However, the current literature has yet to examine the complex interplay between sleep,
disease-related symptoms, and psychosocial factors such as mood and health-related quality of life
in youth with both types of IBD (i.e., Crohn’s disease and ulcerative colitis). Therefore, the
purpose of this study was to examine sleep patterns and associated factors, including pain, disease
activity, mood, and health-related quality of life, in children and adolescents with Crohn’s disease
or ulcerative colitis. A sample of 25 children and adolescents with IBD (Mage = 14.25; range = 1018 years; 56% male) and their caregivers were recruited from a pediatric gastroenterology clinic in
West Virginia. Results indicated no significant association for sleep with abdominal pain, negative
affect, or positive affect. However, significant associations were revealed among sleep and patient
age, disease activity, and health-related quality of life. Youth with IBD also demonstrated greater
sleep disturbance than previously published data using normatively developing samples. Findings
of the current study suggest that children and adolescents with IBD experience significant sleep
disturbance, which may impact their disease activity and psychosocial functioning. Consequently,
healthcare providers should screen for and address sleep difficulties to optimize better outcomes in
their pediatric patients.
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Sleep Patterns and Associated Factors in Children and Adolescents with
Inflammatory Bowel Disease
Inflammatory Bowel Disease (IBD) is a group of chronic medical conditions that are
characterized by an abnormal immune response and gastrointestinal inflammation (Centers for
Disease Control and Prevention [CDC], 2014). In addition, IBD is marked by periods of disease
activity (i.e., symptom flare-ups) and remission, which are unpredictable in nature (Banez, &
Cunningham, 2009). The CDC (2014) currently estimates that 1.4 million individuals in the United
States are living with IBD, of which approximately 10% are children under the age of 18. IBD is
more common in Caucasian individuals than other ethnic groups and is equally prevalent in males
and females (Crohn’s & Colitis Foundation of America [CCFA], 2014). A recent review indicated
a global trend towards increasing incidence of IBD among children and adolescents (Benchimol et
al., 2011). Although the specific cause of IBD is currently unknown, research suggests genetic
factors and immune response to environmental triggers may be involved in the etiology of IBD
(Kim & Ferry, 2004).
Individuals with IBD are diagnosed with one of two disorders, Crohn’s disease (CD) or
ulcerative colitis (UC). Symptoms of both disorders are separated into three categories including
gastrointestinal (e.g., diarrhea, abdominal cramping and pain, rectal bleeding, and constipation),
systematic (e.g., growth failure, weight loss, fever), and endocrine (e.g., delayed puberty,
osteoporosis) (Kim & Ferry, 2004). Despite the similar symptoms associated with intestinal
inflammation, there are aspects that differentiate UC and CD. In UC, inflammation is restricted to
the colon and the top layers of the bowel, while inflammation may occur at part of the
gastrointestinal tract from the mouth to the anus and may impact all layers of the bowel in CD
(CDC, 2014).
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Given the similarity in symptomatology and underlying issue of intestinal inflammation,
UC and CD have similar treatment regimens. Medications designed to reduce inflammation and
frequency of symptom flare-ups in UC and CD include aminosalicylates, immunomodulators,
corticosteroids, anti-tumor necrosis factor (TNF) agents, and antibiotics (CDC, 2014). The CCFA
(2014) currently recommends aminosalicylates to treat mild to moderate disease, corticosteroids
and anti-TNF agents to treat moderate to severe disease, and immunomodulators to be used for
individuals that have not had success with other medications. However, corticosteroids are not
recommended as long-term maintenance medication for IBD given their side effects (e.g., weight
gain, osteoporosis, sleep disturbance) (Buchman, 2001). In addition, antibiotics can be used to treat
infections (CCFA, 2014). Given the nutritional issues present in IBD, patients must maintain a
healthy, well-balanced diet in which they avoid foods that trigger gastrointestinal symptoms (e.g.,
high-fiber and spicy foods) and may require enteral therapy if they experience chronic malnutrition
(CCFA, 2014; Kim & Ferry, 2004). Finally, patients with IBD may require surgery if medications
do not successfully treat symptoms or if complications, such as intestinal blockages, occur (CDC,
2014). Although surgery cures UC by removing the entire colon, patients must have additional
procedures done to create either external or internal pouches to empty waste materials into (CCFA,
2014). In terms of CD, surgery involves the removal of a portion of the bowel, but does not cure
the disease (CCFA, 2014). Thus, patients with CD often have disease recurrences after surgery.
The increasing incidence and issues unique to pediatric IBD, such as embarrassment and
intrusiveness of intestinal symptoms (Banez, & Cunningham, 2009), have generated interest in the
psychosocial functioning of these youth. Therefore, several studies have examined various aspects
of psychosocial functioning, including rates of depression and anxiety, school and social
functioning, family functioning, and health-related quality of life (Greenley et al., 2010; Mackner
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et al., 2013). However, few studies have addressed sleep problems in this population, despite
reports implicating circadian rhythm in gastrointestinal diseases (Hoogerwerf, 2009). Moreover,
those studies that have assessed sleep problems in pediatric IBD have not examined associations
between sleep and the aforementioned psychosocial factors.
Sleep
Sleep has been implicated in various areas of physical health, including growth and
development, immune functioning, and endocrine function (Bryant, Trinder, & Curtis, 2004;
Meltzer & Mindell, 2009). Although sleep is vital to health, sleep problems are common among
children with chronic medical conditions (Palermo & Owens, 2008). Specifically, research has
demonstrated that children with chronic illnesses may experience frequent night awakenings,
problems falling asleep, poor sleep quality, decreased sleep duration, disrupted sleep architecture,
and other sleep disturbances, including sleep-disordered breathing (Lewandowski, Ward, &
Palermo, 2011). Moreover, disturbed sleep can be associated with a host of daytime sequelae,
including fatigue and sleepiness, impaired cognitive and academic functioning, and poor socioemotional functioning (Fallone, Owens, & Deane, 2002; Meltzer & Mindell, 2009; Wolfson &
Carskadon, 2003). Because children with chronic illness are already at risk for some of the
aforementioned problems such as psychosocial distress (Barlow & Ellard, 2006), it is essential to
examine sleep disturbances within this population.
Despite the increasing interest in examining sleep disturbances in chronic medical
conditions, little research has examined this topic in pediatric IBD. However, recent reports have
suggested sleep and circadian rhythms may influence the gastrointestinal system (Swanson,
Burgess, & Keskavazian, 2011). More specifically, Swanson and colleagues explained that sleep
disruption may affect immune functioning, leading to release of inflammatory proteins (e.g.,
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TNF-α) and potentially impacting inflammation of the gastrointestinal tract. In turn, inflammatory
responses have been linked to disturbed sleep among a number of chronic inflammatory
conditions, such as IBD (Ranjbaran et al., 2007b). Given that IBD is characterized by chronic
gastrointestinal inflammation and inflammation disrupts sleep, a vicious cycle may occur in which
patients with IBD have sleep problems and those sleep problems create additional inflammation
(Swanson et al., 2011).
Recognizing the importance of studying sleep in IBD, studies using adult samples have
begun to emerge. These studies indicated that adults with IBD report poor sleep quality (Keefer et
al., 2006; Ranjbaran et al., 2007a; Zimmerman, 2003), have reduced sleep efficiency (Burgess et
al., 2010), and have problems with obstructive sleep apnea (Keefer et al., 2006). Moreover, other
studies have demonstrated a relation between increased disease activity and sleep disturbances in
adults with IBD (Ali et al., 2013; Ananthakrishnan et al., 2013; Graff et al., 2011). Finally, adultbased IBD research has linked sleep disruptions to increased fatigue (Graff et al., 2013) and
decreased quality of life (Keefer et al., 2006; Ranjbaran et al., 2007a). These studies indicate that
sleep problems and associated daytime sequelae are common among adults with IBD, which
emphasizes the importance of continued research in this area.
Although several studies have examined disordered sleep in adults with IBD, relatively
little research has been conducted in pediatric IBD samples. In the first study to investigate this
topic, Nachimas and colleagues (2006) administered the Mini-Sleep Questionnaire to 41 Israeli
children and adolescents with IBD (mean age = 16.9 years). Over half the sample (54%) reported
having moderate or severe sleep disturbance, including daytime fatigue and night awakenings.
However, the authors found no association between sleep problems and medical characteristics
(e.g., disease activity, medications) in their sample. In addition, sleep disruptions and daytime
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sleepiness were examined among a sample of 161 adolescents aged 10 to 18 years with IBD in
comparison to age- and gender-matched healthy peers in Finland (Pirinen et al., 2010). The results
revealed greater parent-reported problems with sleeping, nightmares, and daytime tiredness for
adolescents with IBD compared to healthy adolescents. Interestingly, the adolescents did not
endorse more sleep difficulties than their peers. In contrast, the authors reported an association
between IBD symptom severity and sleep, such that adolescents with more severe IBD reported
more sleep disturbance than those with mild IBD. However, the authors noted that they did not
assess patient use of corticosteroids, which has been shown to disrupt sleep (Huscher et al., 2009),
and thus they are unable to determine the mechanism underlying the sleep disturbance.
Most recently, a study assessed the relations among sleep, psychological functioning, pain,
and inflammation in youth (ages 9 to 17) with depression and CD (Benhayon et al., 2013). In
contrast to Pirinen and colleagues’ (2010) findings, Benhayon and colleagues (2013) determined
that adolescents with IBD reported more sleep difficulties than healthy adolescents. Greater
subjective sleep disturbance among youth with IBD also was associated with increased self-report
depression, anxiety, abdominal pain, as well as more severe physician-reported disease (i.e.,
Pediatric Crohn’s Disease Activity Index), but not inflammation, as assessed by blood assays.
Moreover, qualitative sleep indicators (e.g., sleep quality, daytime sleepiness) were associated with
anxiety, pain, and disease activity, while quantitative sleep indicators (e.g., sleep duration) were
only associated with disease activity. However, because all variables, except disease activity, were
assessed via self- or parent-report questionnaires, the association may have been due to the shared
method variance rather than a true relation between the variables.
The results of the aforementioned studies suggest that youth with IBD may be at risk for
sleep disturbance and thus, it may be important to target sleep problems in future interventions
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within this population. However, all previous studies of pediatric samples have utilized self- or
parent-reported sleep assessments, which may be inaccurate estimates of sleep patterns due to
social desirability or other biases. Moreover, if participants are poor historians, the use of
retrospective questionnaires may not provide accurate data regarding sleep. Therefore, future
research utilizing objective measures, such as polysomnography (PSG) and actigraphy, may
provide more valid assessments of sleep patterns and disturbances. Although PSG is described as
the “gold standard” for assessing sleep and diagnosing sleep disorders (Meltzer & Mindell, 2009),
it involves participants staying overnight in sleep laboratory and is both expensive and timeintensive. In contrast, actigraphy, wrist watch-like devices that assess movement, is a less
expensive and intensive method of examining sleep patterns (Meltzer, Montgomery-Downs, Insana
& Walsh, 2012). As a result, actigraphy allows researchers to more practically evaluate sleep
patterns over time. Overall, research examining of sleep among youth with IBD is in its infancy
and it is clear much additional research is needed to describe sleep/wake patterns in this population
and investigate factors associated with these patterns.
Pain
One common symptom of IBD is abdominal pain. Individuals with IBD may experience
abdominal pain during symptom flares as a result of intestinal inflammation or obstruction
(Bielefeldt, Davis, & Binion, 2009). Although most patients’ pain is relieved during periods of
disease quiescence, some individuals continue to experience some degree of pain despite having
no indication of obstruction or inflammation (Bielefeldt, Davis, & Binion, 2009). Thus,
abdominal pain may be considered a more chronic or continuous, rather than recurrent, symptom
for some patients with IBD and should be monitored during periods of disease activity and
remission. Moreover, it is important to investigate how and to what extent abdominal pain affects
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functioning among individuals with IBD. Specifically, examining the association between pain
and sleep patterns is critical as previous research has demonstrated that disrupted sleep can
influence pain perception and ability to effectively cope with pain in children (Lewin & Dahl,
1999).
Currently, little research specifically has assessed the impact of abdominal pain on sleep
patterns in patients with IBD. Most studies assessing the association between physical symptoms
of IBD and sleep have focused on general measures of disease activity (Ali et al., 2013;
Ananthakrishnan et al., 2013; Graff et al., 2011; Nachimas et al., 2006; Pirinen et al., 2010). To
date, only one study explicitly has evaluated the relation between abdominal pain and sleep
disturbance in pediatric IBD (Benhayon et al., 2013). As previously described, Benhayon and
colleagues demonstrated a positive association between abdominal pain and sleep disturbance in
youth with depression and CD. However, because this study utilized a sample with comorbid CD
and depression, the results may not generalize to patients with UC or patients without depression.
Thus, additional research regarding the relation of pain and sleep in pediatric IBD is warranted.
Although few studies have examined the association between pain and sleep in IBD,
literature using pediatric chronic pain conditions and in particular, functional abdominal pain,
serves as a basis of why pain is an important factor to consider in sleep disturbance. Using a
sample of 25 children and adolescents (ages 10-17) with functional abdominal pain (FAP) and a
sample of 15 age- and gender-matched healthy children, Haim and colleagues (2004) determined
that a greater percentage of children with FAP reported having poor sleep (42%) compared to
healthy children (0%). More specifically, children with FAP reported frequently awakening from
sleep due to abdominal pain, as well as experiencing pain when trying to fall asleep. Interestingly,
no differences were demonstrated between groups with regards to sleep patterns as assessed by
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actigraphy. This finding contradicts the results of other studies, which have demonstrated more
night awakenings and decreased sleep efficiency as assessed by actigraphy among adolescents with
chronic pain conditions (Palermo, Toliver-Sokol, Fonareva, & Koh, 2007). However, Haim and
colleagues noted that their study was underpowered to examine differences in objective sleep
measurements, which may have accounted for their lack of significant group differences.
Additionally, a study by Huntley and colleagues (2007) investigated the association
between sleep disturbance and pain while controlling for psychopathology (i.e., depression and
anxiety disorder diagnoses) in 67 youth aged 8-15 years with FAP compared to 80 healthy peers.
Results revealed greater parent- and child-reported sleep disturbance, including poorer sleep
quality, more nightmares, and more problems falling asleep and staying asleep, in youth with FAP
than in healthy children. No differences in total sleep time were demonstrated, suggesting youth
with FAP may have more disruptions in sleep quality rather than duration. Moreover, the authors
determined having pain was significantly associated with increased sleep disturbance above and
beyond the influence of psychopathology.
Taken together, the current literature indicates that pain is a critical factor to consider in the
study of sleep in children and adolescents with IBD. Even though pain has only been examined in
one study with pediatric CD, studies of other chronic pain samples suggest that pain is associated
consistently with subjective sleep disruptions. However, the literature evaluating the relation of
pain to objective sleep disturbance have yielded mixed results, indicating that additional research
needs to be conducted to clarify this relation. Furthermore, previous studies in pediatric sickle cell
disease have demonstrated a cyclical relation between pain and sleep problems, in which greater
pain severity during the day is associated with worse sleep at night and worse sleep at night is
associated with greater pain severity the next day (Valrie, Gil, Redding-Lallinger, & Daeschner,
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2007). Therefore, future research should investigate the association between pain and sleep
problems in pediatric IBD using a prospective design to determine if Valrie and colleagues’ (2007)
results extend to other pediatric illness samples.
Psychological Functioning
Given the unique issues of pediatric IBD, such as embarrassment and intrusiveness
regarding intestinal symptoms (Banez, & Cunningham, 2009), much research has been conducted
to examine the psychosocial functioning of these youth (Greenley et al., 2010; Mackner et al.,
2013). Overall, the research has demonstrated that children and adolescents with IBD have higher
rates of internalizing symptoms (i.e., depression and anxiety) than samples of healthy children and
youth with other pediatric chronic illnesses. In addition, disease severity, stress, family functioning,
and maternal psychopathology have been correlated with internalizing symptoms in these youth
with IBD (Greenley et al., 2010; Mackner et al., 2013). Because sleep disturbances have been
associated with both depressive and anxious symptomatology among healthy children and
adolescents (Chorney, Detweiler, Morris, & Kuhn, 2008), it makes sense that these associations
may be present among youth with chronic medical conditions who have additional disease-related
stressors.
Among youth with IBD, only one study has explored the relation between psychological
functioning and sleep (Benhayon et al., 2013). The results revealed an association between
subjective sleep disturbance and internalizing symptoms such that youth who reported more
sleep problems also reported greater depressive and anxious symptoms. However, as previously
noted, this study has a number of limitations, including limited generalizability to youth with UC
or without a diagnosis of depression, use of subjective measures only, and use of a
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cross-sectional design that does not allow for conclusions regarding directionality or causality of
associations.
An examination of the pediatric chronic pain literature again provides additional rationale
investigating the interplay between internalizing disorders and sleep. For example, Palermo and
colleagues (2007) assessed sleep and associated factors, such as depression and worry before
bedtime, among a sample of 20 adolescents (ages 12 to 17) with FAP, chronic headaches,
myofascial pain, or type 1 complex regional pain syndrome. The authors found a relation
between greater worry before bedtime and depressive symptoms and greater subjective sleep
problems; however, objectively measured sleep was not significantly associated with depression
or worry. This lack of association between internalizing symptoms and actigraphy results may be
due to the way in which the authors analyzed the data. The authors chose to compute average
measures of objective sleep to analyze this association rather than evaluating the relation of sleep
and psychological symptoms in a prospective design, as Valrie and colleagues (2007) did in their
sample of children with sickle cell disease. A prospective design may capture more variability in
sleep patterns and psychological symptoms, and thus, may yield different results. Using a larger
sample of adolescents with pain that was not related to a chronic disease, Palermo and colleagues
(2011) determined pre-sleep arousal but not depressive symptoms were associated with greater
subjective sleep disturbance. In a study of 26 female adolescents aged 12 to 17 years with
musculoskeletal pain, Meltzer and colleagues (2005) also demonstrated a positive correlation
between internalizing symptoms (i.e., depression and anxiety) and daytime sleepiness, but not
between internalizing symptoms and nighttime sleep. The authors explained that their sample did
not differ from a healthy sample of adolescents on total sleep time and this lack of difference,
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coupled with the pain sample’s low ratings of depression and anxiety, may have accounted for
the lack of significant relation between internalizing symptoms and nighttime sleep.
Overall, youth with IBD may be at a greater risk for experiencing internalizing symptoms
compared to their healthy peers and these symptoms may be related to more disrupted sleep.
However, only one study has assessed the association between psychological symptomatology and
sleep in pediatric IBD. Research from other pediatric chronic pain samples have produced mixed
results regarding this relation, with some studies suggesting a significant relation exists (Palermo et
al., 2007; Palermo et al., 2011) and other studies suggesting it does not (Meltzer et al., 2005). In
addition, multiple methods of measuring sleep have been utilized (i.e., self-report measures,
actigraphy), which may contribute to the discrepancies between studies. Given the limited
literature, future research should continue exploring the association of internalizing symptoms and
sleep in pediatric chronic medical conditions and specifically, in pediatric IBD, using a multimethod approach.
Health-related Quality of Life
Health-related quality of life (HRQOL) has been defined as “a broad multidimensional
concept that usually includes self-reported measures of physical and mental health” (CDC, 2012).
HRQOL is commonly measured in pediatric psychology studies to assess youth adjustment to
having a chronic medical condition (Palermo et al., 2008). In terms of pediatric IBD, many studies
identified and described factors associated with HRQOL (Greenley et al., 2010; Mackner et al.,
2013). Findings from these studies reveal lower youth- and parent-reported HRQOL among
children and adolescents with IBD compared to healthy peers. Moreover, corticosteroid use,
greater disease severity, older age, ineffective coping skills, depression, and poor family
functioning have been associated with worse HRQOL in these youth (Mackner et al., 2013).
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The association of sleep with HRQOL has been examined in several pediatric chronic
medical conditions, including liver transplant recipients and juvenile idiopathic arthritis and
juvenile dermatomyositis. For instance, Fredericks and colleagues (2012) assessed parent-reported
sleep disturbance and HRQOL among 47 patients aged 2-17 years who had undergone liver
transplants. Their results revealed that children who were reported to have sleep disturbance,
especially periodic limb movements and daytime sleepiness, had lower parent-reported HRQOL.
Additionally, lower child-reported school functioning was associated with more daytime
behavioral sequelae (i.e., inattention and hyperactivity). Using a sample of 155 patients with either
juvenile idiopathic arthritis or juvenile dermatomyositis (ages 8 to 16), another study demonstrated
that sleep problems and fatigue were inversely related to HRQOL (Aviel et al., 2011). Specifically,
greater parent- and child-reported sleep disruption and fatigue were associated with worse overall
HRQOL and disease-specific quality of life. However, because both studies relied entirely on
subjective measures, it is possible the associations were inflated due to shared-method variance and
that utilization of objective measures may yield different results.
Although no studies have examined the relation between sleep disturbance and HRQOL
in pediatric IBD, Marcus and colleagues (2009) evaluated subjective fatigue and HRQOL in a
sample of 70 children with IBD and 157 healthy children (ages 10-17). Compared to healthy
youth, children and adolescents with IBD reported significantly poorer HRQOL and greater
fatigue. Greater fatigue also was associated with worse HRQOL among youth with IBD.
Moreover, youth with more severe IBD reported greater fatigue and poorer HRQOL than those
youth with more mild disease. The results of this study provide some indication that an
association between sleep problems and HRQOL may exist in pediatric IBD as fatigue and sleep
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are closely linked. However, it is clear that future studies are needed to determine whether an
actual relation between sleep disturbance and HRQOL exists in this population.
Additionally, one study has investigated the associations among sleep problems, pain,
depression, functional disability, and HRQOL in adolescents with various chronic pain conditions,
including sickle cell disease, chronic headache, and juvenile idiopathic arthritis (Palermo & Kiska,
2005). Their results demonstrated that greater reported sleep disturbance was related to greater
depressive symptoms, more frequent reports of pain, increased functional disability, and reduced
social and emotional HRQOL. Furthermore, depressive symptoms accounted for a significant
amount of the variance in sleep disruption after controlling for the effects of pain, functional
disability, and HRQOL. The authors explained that because their study utilized a cross-sectional
design, future research should be conducted to explore the prospective associations between sleep,
HRQOL, pain, and mood in pediatric samples.
Previous research suggests that HRQOL is a critical factor to consider in the study of sleep
of youth with IBD. Even though this association has not been examined in pediatric IBD, studies
with other chronic illness groups suggest that HRQOL is associated consistently with sleep
disruption. Lastly, Palermo and Kiska’s study (2005) suggests that the interplay between pain,
mood, and HRQOL may be important to consider when studying sleep disturbance and promoting
healthy sleep habits in youth with chronic medical conditions, including IBD.
Summary of Relevant Literature and Rationale for Current Study
IBD is characterized by an abnormal immune response and gastrointestinal inflammation,
and consists of both Crohn’s disease and ulcerative colitis (CDC, 2014). Both disorders are marked
by a number of symptoms, such as diarrhea, abdominal cramping and pain, rectal bleeding, weight
loss, fever, delayed puberty, and osteoporosis (Kim & Ferry, 2004). The course of IBD is
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unpredictable in nature, with periods of symptom flare-ups and disease quiescence (Banez &
Cunningham, 2009). Treatment for IBD includes medication (e.g., aminosalicylates and
corticosteroids), maintaining a healthy diet that excludes foods known to trigger symptoms, and
potentially surgery if complications occur (CCFA, 2014). Given the increasing incidence of IBD in
youth (Benchimol et al., 2011), much research has emerged regarding psychosocial functioning
and disease sequelae, such as fatigue, among individuals with IBD. However, few studies have
examined the role of sleep in pediatric IBD.
Recent research has suggested there may be a bi-directional relation between sleep
disruption and gastrointestinal inflammation in which patients with IBD have sleep problems and
those sleep problems create additional inflammation (Swanson, Burgess, & Keskavazian, 2011).
This has spawned a number of studies with adult patients with IBD, which have demonstrated that
sleep problems and associated daytime sequelae are common in this population (Ali et al., 2013;
Ananthakrishnan et al., 2013; Burgess et al., 2010; Keefer et al., 2006; Graff et al., 2011; Graff et
al., 2013; Ranjbaran et al., 2007a; Zimmerman, 2003). Among pediatric IBD samples, far less
research has been conducted on sleep disturbance (Benhayon et al., 2013; Nachimas et al., 2006;
Pirinen et al., 2010). The results of these studies indicated youth with IBD may be at risk for sleep
disturbance, including poor sleep quality, night awakenings, and daytime sleepiness. Furthermore,
a positive association between disease activity and sleep disruption was demonstrated in two of the
studies (Benhayon et al., 2013; Pirinen et al., 2010) However, all three pediatric studies are limited
by their use of subjective sleep assessments that can be influenced by an individual’s biases. Thus,
future research should consider using objective measures, such as PSG and actigraphy, to provide
more accurate estimates of sleep patterns and disturbances in this population.
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In addition to describing sleep patterns using multiple methods, it is important to determine
what factors are associated with sleep disturbance based on previous research examining
functioning of youth with IBD and research exploring psychosocial factors with other pediatric
chronic medical conditions. Such research has revealed that children and adolescents with IBD
experience high rates of internalizing symptoms (i.e., depression and anxiety) and poor HRQOL
(Greenley et al., 2010; Mackner et al., 2013). Studies using pediatric chronic pain samples also
have linked greater internalizing symptoms and worse HRQOL to greater sleep disruption (Aviel et
al., 2011; Palermo et al., 2007). Moreover, abdominal pain is common symptom of IBD and
research with pediatric FAP has demonstrated a positive association between pain and sleep
disturbance (Haim et al., 2004; Huntley et al., 2007). Therefore, it seems reasonable that the
aforementioned factors would be related to sleep problems among youth with IBD.
However, only one study to date has evaluated the association between pain, psychological
functioning, and sleep in pediatric IBD (Benhayon et al., 2013). The authors determined that youth
who reported more sleep difficulties also reported greater depressive and anxious symptoms.
Moreover, the results revealed an association between abdominal pain and sleep such that greater
reports of pain were related to greater subjective sleep disturbance. Although this study added to
the literature by examining factors related to sleep disruption in youth with IBD, it has a number of
limitations, including limited generalizability to youth with UC or without a diagnosis of
depression, use of subjective measures only, and use of a cross-sectional design that does not allow
for conclusions regarding directionality or causality of associations. These limitations point to a
need for future research using objective assessments, a prospective design, and a sample including
both pediatric CD and UC.
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Although no studies have explored the association between HRQOL and sleep in pediatric
IBD, Marcus and colleagues (2009) found that poorer HRQOL was related to greater subjective
fatigue among youth with IBD. These results suggest that more research needs to be conducted in
this population, as fatigue and sleep are closely linked but are two separate constructs. Moreover,
looking to the field of pediatric chronic pain provides rationale for investigating the interplay
among sleep, pain, depression, and HRQOL. Using a sample of adolescents with various pain
conditions, Palermo and Kiska (2005) demonstrated that greater depressive symptoms, more
frequent reports of pain, and reduced social and emotional HRQOL were associated with more
sleep disruption. Their results also indicated that depressive symptoms are strongly related to sleep
disturbance after accounting for the effects of pain and HRQOL. However, given the crosssectional nature of Palermo and Kiska’s (2005) study, additional research should utilize
prospective designs to explore the associations between sleep, HRQOL, pain, and mood over time.
Taken together, the results of the aforementioned studies suggest that pain, disease activity,
mood, and HRQOL may be important factors to consider in the investigation of sleep patterns and
disturbances in children and adolescents with IBD. Moreover, these factors may be considered
targets of future interventions designed to promote optimal sleep in this population. Therefore, the
purpose of this study is to examine sleep patterns and associated factors, including pain, disease
activity, mood, and health-related quality of life, in children and adolescents with IBD. More
specifically, the specific aims and hypotheses of the current study are as follows:
Aim 1: To describe objectively measured sleep patterns, including total sleep time, sleep onset
latency, sleep efficiency and wake after sleep onset, and subjective sleep habits among children
and adolescents with IBD and compare to data from previously published studies using healthy
samples.
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Aim 2: To examine the associations between subjective sleep patterns (1-week parent or 2-week
patient retrospective report), objective sleep patterns (aggregated measures of total sleep time,
sleep onset latency, sleep efficiency, and wake after sleep onset across 14-day study period),
disease activity (at study enrollment), and health-related quality of life (2-week retrospective
report) among children and adolescents with IBD. Based on previous research within samples of
pediatric IBD and other chronic medical conditions (e.g., Benhayon et al., 2013; Pirinen et al.,
2010), the following hypotheses were proposed:
•

Hypothesis 2a: Youth who are rated by physicians as having greater disease activity will
have greater subjective and objective sleep disturbance.

•

Hypothesis 2b: Youth who report worse health-related quality of life will have greater
subjective and objective sleep disturbance.

•

Hypothesis 2c: Youth who have worse parent-reported health-related quality of life will
have greater subjective and objective sleep disturbance.

Aim 3: To examine the associations between objective sleep patterns, abdominal pain, and
negative affect across a 14-day period among children and adolescents with IBD. Based on
previous research within samples of pediatric IBD and other chronic medical conditions (e.g.,
Benhayon et al., 2013; Gil et al., 2003; Pirinen et al., 2010; Valrie et al., 2007), the following
hypotheses were proposed:
•

Hypothesis 3a: Youth who report experiencing more intense pain during the day will have
more objective sleep disturbance that night.

•

Hypothesis 3b: Youth who have more objective sleep disturbance at night will report
experiencing more intense pain the next day.
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•

Hypothesis 3c: Youth who report more negative affect during the day will have more
objective sleep disturbance that night.

•

Hypothesis 3d: Youth who have more objective sleep disturbance at night will report
experiencing more negative affect the next day.

Aim 4: To explore the association between objective sleep patterns and positive affect across a 14day period among children and adolescents with IBD.
•

Hypothesis 4: Because there is no previous literature on the association of positive affect
and sleep, this aim was exploratory and thus, no hypothesis was generated.
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Method
Participants
Fifty-one children and adolescents with IBD and their primary caregivers were approached
regarding participation in the current study. Patients were recruited from West Virginia
University’s pediatric gastroenterology clinic or via recruitment letters sent to all patients on the
gastroenterology clinic registry. This study included children and adolescents who: a) were
between ages 10 and 18 years; b) had a diagnosis of Crohn’s disease or ulcerative colitis for at least
3-4 months (to help ensure patients have been medically stabilized after initial diagnosis); c) were
either currently experiencing disease activity or in a period of disease quiescence; and d) had a
primary caregiver who was willing to participate with the patient. Patients who were judged to be
unable to complete the study questionnaires were not recruited for the current study. Of those
approached, 40 patients agreed to participate (22% refusal rate). Reasons for refusal included lack
of interest in the study (n = 4) and being too busy to complete study measures (n = 7). No
significant differences in terms of patient age, gender, or race were demonstrated between
participants and non-participants. Four additional participants withdrew from the study due to lack
of interest. Ten participants did not complete the current study measures or actigraphy and were
considered lost to follow-up. One participant was excluded from all analyses due to lack of selfreported bedtimes and wake times and inability to corroborate actigraphy data. Demographic data
for the final sample of 25 youth are presented in Table 3. The mean age of patients was 14.25 years
(SD = 2.42) and 56% of the patients were male. Primary caregivers who participated were
primarily mothers (88%). The majority (80%) of participants was diagnosed with Crohn’s disease
and was in a state of disease remission (80%). Participants who were rated as being in a state of
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disease remission did not significantly differ on demographic characteristics (i.e., age, gender, race,
and ethnicity) compared to those who were rated as having active disease.
Procedure
During routine clinic appointments, potential participants were identified by healthcare
staff and asked if they were interested in hearing about a research study. After participants agreed
to hear about the study, a research assistant described the study’s purpose and procedures as well
as potential risks and benefits of participation in a private clinic room. The research assistant also
discussed confidentiality and HIPAA guidelines with the family. If participants agreed to the study,
the research assistant obtained informed consent from the patient’s primary caregiver and patients
aged 18; assent also was obtained from patients aged 8-18 In addition, a letter describing the
study’s purpose and procedures was mailed to all eligible patients and their families in the patient
registry in an effort to recruit patients who do not attend clinic appointments regularly. Families
were instructed to contact research staff by phone if interested in participating. A member of the
research staff then scheduled an appointment to review the consent and assent forms and
questionnaires either over the phone, at clinic, the family’s home, or a mutually agreed upon public
location. Phone numbers and/or email addresses of participating families were collected on the
consent forms to contact them regarding reminders to complete study measures, to arrange to pick
up study materials, if needed, and to contact families who won a gift card in the lottery at the end
of the study. Of participants who completed the study, 23 were recruited in clinic, while three were
recruited via mailings.
After being consented, each family was given a packet of questionnaires that are unrelated
to the current study to complete at home and send back using pre-addressed, stamped envelopes.
After these questionnaires were received, a research assistant mailed out an actigraph, instructions

20

for actigraph use, a packet of questionnaires for participants to complete during the 14-day study
period, and pre-addressed, stamped envelopes. This method was utilized to help determine the
family’s trustworthiness in returning study questionnaires and equipment. Research assistants also
called or emailed participants after packets were sent out to review instructions for completing the
questionnaires and wearing the actigraph (also referred to as “actiwatch”). Patients were instructed
to wear the actigraph on their non-dominant wrist at all times, except during bath time or when the
actigraph may be submerged in water (e.g., washing dishes, swimming), for 14 days following
receipt of study packet. Patients (or parents, depending on patient’s age) were instructed to depress
a button on the actiwatch until it clicked at bedtime and upon awakening in the morning. The
research assistant instructed families to consider the patient’s “first opportunity to attempt to sleep
alone” as bedtime/time to depress the actiwatch button at night. The research assistant also
instructed families to consider the time at which the patient “awoke in the morning without going
back to sleep” as the patient’s wake time/time to depress the actiwatch button in the morning. In
addition, families were instructed to complete the Sleep Diary with information regarding
nighttime awakenings each morning. For the remainder of the daily measures (i.e., Sleep Diary nap
information, Pain Diary, PANAS), patients were instructed to complete them as close to bedtime as
possible in an effort to capture information from the entire day.
Within each questionnaire packet, the parents completed the following questionnaires on
day 1 (Time 1): a) Family Information Form (may be have been completed with patient if
appropriate); and b) Child Sleep Habits Questionnaire. Also at Time 1, the patients completed the
following questionnaires: a) Pain & Sleep Diary; b) Positive and Negative Affect Schedule for
Children (PANAS-C); and c) Sleep Habits Survey. For days 2-13, patients completed the following
measures in addition to wearing the actigraph: a) Pain & Sleep Diary; and b) Positive and Negative
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Affect Schedule for Children. On day 14 (Time 2), both patients and parents completed the
IMPACT-III. Table 1 displays the overall study flow. In addition to the questionnaire packets, the
patient’s physician completed either the Pediatric Crohn's Disease Activity Index or the Pediatric
Ulcerative Colitis Activity Index, depending on the patient’s diagnosis, when the patient was
recruited in clinic. The physician was blinded to study data when completing the aforementioned
measures of disease activity. The physician also reviewed the participants’ medical charts and
recorded dates of symptom flares in the year prior to recruitment date.
A research assistant called, emailed, and/or sent a text message (depending on family
preference) to each family twice a week during the 14-day study period to remind them to
complete the daily questionnaires and to answer any questions families had at the time. At the end
of the study period, families mailed all questionnaires and actigraph equipment back to the WVU
Department of Psychology using pre-addressed, stamped envelopes. If families did not mail the
equipment back after completion of data collection, a research assistant called the family to arrange
to pick up the study materials either at their home, in clinic, or a public location. For their
participation in the study, families received up to $75 in gift cards and cash. For completion of
Time 1 questionnaires, patients and parents each received a $10 gift card (total of $20 in gift
cards). In terms of days 2-13, patients were paid $2.50 in cash for each day they completed the
measures (i.e., Pain & Sleep Diary, PANAS-C, actigraphy). Moreover, patients received an
additional $5 in cash if they completed all study measures during days 2-13. Similar to Time 1,
patients and parents each received a $10 gift card for completion of Time 2 questionnaires. In
addition, families who returned the actigraphy equipment in working order were entered into a
lottery to receive one of five $50 gift cards (see Table 2 for schedule of participant remuneration).
The lottery was conducted at the conclusion of all data collection.
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Measures
Family Information Form. The Family Information Form was created for this study to
collect data on demographic and medical information about the patient and primary caregiver, such
as patient and primary caregiver age, ethnicity, education level, and patient medical history. In
addition, parents completed items on sleep health beliefs for their child and knowledge regarding
sleep in youth that were based on questions from the Parental Knowledge of Healthy Sleep in
Children (Owens, Jones, & Nash, 2011).
Child Sleep Habits Questionnaire (CSHQ; Owens, Spirito, & McGuinn, 2000). The
CSHQ is a 35-item parent-report questionnaire that assesses the sleep habits of children during the
past week. Although the CSHQ was originally developed based on a sample of parents of children
ages 4 to 10 years, it was completed by parents of all children in the current study. The CSHQ
yields a total sleep disturbance score and eight subscales, including bedtime resistance, sleep onset
delay, sleep duration, sleep anxiety, night wakings, parasomnias, sleep-disordered breathing, and
daytime sleepiness. Parents rated their child’s sleep on a 3-point Likert-type scale (“usually/5 or
more times a week,” “sometimes/2-4 times a week,” and “rarely/0-1 times a week”). Parents also
indicated whether each sleep habit was a problem or not and whether their child was “very sleepy”
or “falls asleep” during various daytime activities (e.g., eating meals, riding in a car). Finally,
parents listed the child’s average bedtime and wake time, as well as average sleep duration on
weekends and weekdays and average duration of night awakenings across the one-week period.
Several items are reverse-scored, so higher scores indicated greater sleep disturbance. Subscales
are calculated by summing relevant items, and the total sleep disturbance score is the sum of all
subscales. Owens and colleagues (2000) reported high specificity and sensitivity for distinguishing
between children with sleep disorders and those without sleep disorders.
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For the current study, all subscales and the total sleep disturbance score were calculated to
describe the patient’s sleep habits. In addition, average total sleep duration and night awakening
duration during the past week was calculated to provide descriptive information for the sample.
Within the current study, internal consistency for the total sleep disturbance was .68. Internal
consistency for CSHQ subscales ranged from .08 (daytime sleepiness) to .82 (night wakings).
Pain & Sleep Diary. The Pain & Sleep Diary was created for this study to collect data on
each patient’s daily pain and sleep throughout the 14-day study period. Patients rated their
abdominal pain intensity each day on a 0 to 10 Likert-type scale with 0 = “no pain” and 10 =
“worst pain ever.” Patients also completed items regarding time and duration of night awakenings
and daytime naps to corroborate data gathered from the actiwatches. In addition, planned wake
time, reasons for nighttime awakenings, use of corticosteroids, as well as times of taking the
actiwatch off and putting it back on were recorded in the diary.
Positive and Negative Affect Schedule for Children (PANAS-C; Laurent et al., 1999).
Patients completed the PANAS-C to assess positive and negative affect daily. The PANAS-C was
specifically chosen because it assesses multiple dimensions of mood (including sadness and
anxiety, which have been examined in previous literature [e.g., Benhayon et al., 2013], as well as
positive aspects of mood, such as happiness) and is a self-report measure that can assess changes in
mood on daily basis. The PANAS-C consists of 30 items, 15 assessing positive affect and 15
assessing negative affect. Patients rated their mood using different words (e.g., happy, sad,
nervous) on a 5-point Likert-type scale from 1 = “very slightly or not at all” to 5 = “extremely.”
This questionnaire yields both positive and negative affect scores. To score each scale, the sum of
the items for that scale was calculated. Higher scores equal greater negative or positive affect.
Previous studies indicate the PANAS-C has good discriminant and convergent validity with
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self-report, validated measures of anxiety and depression among children in grades 4 through 8
(Laurent et al., 1999). In addition, this measure has been previously utilized in youth ages 11 to 20
with sickle cell disease (Zempsky et al., 2013). For this study, both positive and negative affect
scores were utilized. Cronbach’s alpha coefficients varied by day across the 14-day study period
and ranged from .72 (on day 3) to .95 (on day 14) for negative affect and .81 (on day 11) to .96 (on
day 3) for positive affect.
Sleep Habits Survey (SHS; Wolfson & Caskadon, 1998). Youth completed the SHS to
assess their perceptions of their sleep habits during the previous two weeks. The SHS is a 63-item
measure of sleep habits and school performance; however, only the 40 items assessing sleep habits
were utilized for this study. The SHS includes items that measure total sleep time, bedtime, and
wake time on weekdays and weekends, as well as three subscales (sleepiness scale, sleep/wake
problems scale, and morningness/eveningness scale). On the sleepiness scale, patients rated their
level of sleepiness during various activities on a 4-point Likert-type scale (1 = “no sleepiness” to 4
= “struggled to stay awake or fell asleep”). Higher scores indicate greater daytime sleepiness.
Patients also rated the frequency of their problems with sleeping and waking from 1 = “never” to 5
= “everyday,” with higher scores indicating greater sleep and wake problems. Lastly, patients
completed the morningness/eveningness scale, which presents different scenarios to determine
sleepiness and alertness in the morning versus evening. Higher scores indicate a morning
preference while lower scores indicate an evening preference. Wolfson and colleagues (2003)
found moderate to high correlations between the SHS and sleep diaries and actigraphy, indicating
good convergent validity. For the current study, all three subscales were calculated to describe
youth-reported sleep habits (i.e., sleepiness scale, sleep/wake problems scale, and
morningness/eveningness scale). In addition, average total sleep time during the previous two
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weeks was calculated for the sample. In the current study, the SHS demonstrated variable internal
consistency for the subscales (i.e., sleepiness scale = .55, sleep/wake problems scale = .80, and
morningness/eveningness scale = .72).
Pediatric Crohn's Disease Activity Index (PCDAI; Hyams et al., 1991). The PCDAI is a
physician-report assessment of disease activity of children and adolescents with Crohn’s disease.
The PCDAI is a 12-item questionnaire that assesses several domains related to disease activity in
Crohn’s disease, including abdominal pain, stools, patient general well being, laboratory values,
and physician examination questions. Scores on the abdominal pain, stools, and patient general
well-being items range from 0 (“no/minimal problems”) to 10 (“severe problems”). Laboratory
values are converted to a scoring system ranging either from 0 to 5 or 0 to 10. The physician
examination items assess patient height, weight, tenderness of abdomen, perirectal disease, and
extraintestinal manifestations, and can be categorized as 0, 5, or 10. Items are summed to create a
total disease activity score. Total scores range from 0 to 100, with higher numbers corresponding
to greater disease activity. Patients can be categorized as having “inactive disease” (scores less than
10), “mild disease” (scores of 11-30), or “moderate to severe disease” (scores greater than 30).
Studies of the PCDAI reveal good specificity and sensitivity for identifying periods of moderate or
severe disease activity among youth aged 8 to 15 (Hyams et al., 2005). Patients were categorized
into three aforementioned groups for subsequent analyses.
Pediatric Ulcerative Colitis Activity Index (PUCAI; Turner et al., 2007). The PUCAI is a
physician-report assessment of disease activity of children and adolescents with ulcerative colitis.
The PUCAI is a 6-item questionnaire that assesses six disease activity domains: abdominal pain,
rectal bleeding, stool consistency, number of stools per day, nocturnal stools, and activity level.
Abdominal pain, stool consistency, and activity level items are rated on a 3-point scale (0, 5, 10),
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while the items related to rectal bleeding and number of stools are rated on a 4-point scale (0, 10,
20, 30 or 0, 5, 10, 15, respectively). Finally, the nocturnal stools item is rated as either 0 or 10. All
items are summed to create a total disease activity score that ranges from 0 to 85, with higher
scores indicating greater disease activity. Patients can be categorized into one of four groups: a)
“disease remission” (scores less than 10), b) “mild disease” (scores of 10-34), c) “moderate
disease” (scores of 35-64), and d) “severe disease” (scores greater than 65). For the current study,
the categories of “moderate disease” and “severe disease” were combined into one group to enable
consistency across the PCDAI and PUCAI: “moderate to severe disease” (scores greater than 35).
The PUCAI has demonstrated good inter-observer reliability (ICC = .95) and convergent validity
with other assessments of disease activity, such as colon appearance measured via colonoscopy, in
samples of youth ages 3 to 18 years (Turner et al., 2007). Disease activity was analyzed using three
categories of “remission,” “mild,” and “moderate to severe” disease.
Actigraphy (Mini Mitter Actiwatch-64; Bend, Oregon). The Mini Mitter Actiwatch-64 is a
wristwatch-like device used to assess sleep/wake patterns. The actiwatch measures sleep/wake
patterns by using an accelerometer to monitor movement. The actiwatch was worn on the patient’s
non-dominant wrist for 14 consecutive days. Patients (or parents, depending on the patient’s age)
pressed a button on the actiwatch at bedtime and upon awakening in the morning, which places an
event marker within the data being collected. The actiwatch was programmed to the 30-second
epoch setting to allow for continuous monitoring during the 14-day study period. Based upon the
movement data, several sleep-related measurements were determined using the Actiwatch
software: a) sleep onset; b) sleep onset latency (i.e., time between reported bedtime and sleep
onset); c) wake time; d) wake after sleep onset (i.e., minutes awake during sleep period); e) total
sleep time (i.e., duration between sleep onset and wake time minus duration of wake after sleep
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onset); and f) sleep efficiency (i.e., total sleep time divided by time in bed) (Meltzer et al., 2012).
Sleep onset latency, total sleep time, sleep efficiency, and wake after sleep onset were used in
analyses.
A review of the literature on actigraphy use in pediatric samples determined that actigraphs
have high sensitivity for identifying sleep and low specificity for identifying wake after sleep onset
in comparison to polysomnography, videosomnography, and direct observation (Meltzer et al.,
2012). More specifically, studies using samples of ages similar to that of the current study and the
Actiwatch-64 found sensitivities ranging from 78.1 – 96.5 and specificities ranging from 39.4 –
52.6 (Hyde et al., 2007; O’Driscoll et al., 2009). However, actigraphy provides an objective
method of assessing sleep/wake patterns that is more ecologically valid than the “gold standard” of
sleep assessment, that being polysomnography.
IMPACT-III (Otley et al., 2002; Otley et al., 2006). The IMPACT-III is a health-related
quality of life measure designed for use in children and adolescents (ages 9 to 18 years) with IBD
over the past two weeks. The IMPACT-III is a 35-item scale that assesses six areas of quality of
life: bowel symptoms, systemic symptoms, emotional functioning, social functioning, body
image, and treatment interventions. Patients rated their quality of life for each subscale using a 5point Likert-type scale. Scores are transformed from 0 – 5 to a 0 – 100 scale for interpretation (0
= 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), with higher scores corresponding to greater quality of life.
A total quality of life score and six individual domain scores can be obtained by computing the
mean score of either all the questions answered (total score) or the mean score of the questions
answered under the individual domain (individual domain scores). The IMPACT-III was
responsive to change in quality of life based on disease activity (Otley et al., 2006). A previous
version of the IMPACT-III demonstrated convergent validity with other measures of quality of
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life (Otley et al., 2002). For the current study, this measure was adapted to create a parent-report
version so parents also could provide proxy ratings of their child’s quality of life. Only the total
quality of life score (parent and patient report) was used for study analyses. The IMPACT-III
demonstrated high internal consistency for both the patient- and parent-report versions in this
study (α = .91 and .93, respectively).
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Results
All statistical analyses were conducted through use of Predictive Analytics Software and
Solutions version 21 (SPSS 21).
Power analyses.
Statistical power for multilevel modeling approaches is based on the number of
observations rather than the number of persons and allows for detection of effects using small
sample sizes (Curran, Obeidat, & Losardo, 2010;Schwartz & Stone, 1998). Using a sample of 37
adolescents with sickle cell disease, Gil and colleagues (2003) found medium to large effect sizes
for the association of negative mood (β = 0.36, t = 8.55, p < .0001) and positive mood (β = – 0.4, t
= –10.09, p < .0001) to same-day pain. In addition, Valrie and colleagues (2007) found a large
effect size for the relation of sleep quality to pain severity in a sample of 20 children with sickle
cell disease (β = – 6.54, t = – 8.18, p < .01). Moreover, results of Benhayon and colleagues’ (2013)
study of adolescents with CD revealed medium to large effect sizes regarding the association of
sleep disturbance with disease activity (R2 = 21.6, p < .0001), anxiety (R2 = 8.6, p = .005), and
abdominal pain (R2 = 15.7, p = .0001). Because the aforementioned studies used multilevel
modeling techniques to examine variables similar to those in the current study, it is assumed that
effect sizes in this study will be comparable. Therefore, this study aimed to recruit approximately
25-30 participants to detect a medium to large effect size.
Preliminary analyses.
All participants with at least seven days of diary and actigraphy data including both
weekdays and weekends were retained in the final sample for analyses. First, all data were
reviewed to locate any missing data for Aims 1 and 2, and to ensure that all missing data were
random. Review of data revealed minimal amounts of missingness across study variables. Two

30

participants were missing data from the entire CSHQ and one participant was missing data from
the entire SHS. These participants were excluded for relevant analyses in aim 2. Person-mean
imputation (i.e., substituting the participant’s mean score of completed items on a scale for the
items that were not completed) was utilized to address missingness for questionnaire data (i.e.,
SHS, CSHQ, IMPACT-III) for other participants (all who had less than 10% missing data).
Imputation was not utilized to address missingness among diary data, PANAS-C, and actigraphy
given that these data were examined utilizing multilevel modeling. Multilevel modeling allows for
the analysis of unequal amounts of data and includes methods for handling missing data, such as
multiple imputation and maximum likelihood estimations (Schwartz & Stone, 1998).
Next, study variables were examined for skewness, kurtosis, and outliers. These analyses
revealed 5 outliers and 5 kurtoic variables (CSHQ bedtime resistance subscale, CSHQ sleep
anxiety subscale, CSHQ parasomnias subscale, CSHQ sleep disordered breathing subscale, SHS
sleep-wake problems subscale). No skewed variables were revealed. To attempt to correct these
issues, square root, log, and inverse transformations were performed. These transformations
corrected the outlier and kurtoic issues among three variables (CSHQ bedtime resistance subscale,
CSHQ sleep anxiety subscale, SHS sleep-wake problems subscale) and these transformed variables
were utilized in subsequent analyses. However, none of the transformations corrected the kurtosis
or outlier issues for CSHQ parasomnias and CSHQ sleep disordered breathing subscales and
therefore, the variables were retained in their original form. Descriptive statistics for all primary
study variables are presented in Table 4. Additionally, frequency information for the parental
beliefs and sleep knowledge questions from the FIF are presented in Table 5.
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Aim 1.
The first aim was to describe objectively measured sleep patterns and subjective sleep
habits. First, objective sleep data were aggregated across the 14-day study period for each
participant using the four variables of interest (i.e., total sleep time, sleep onset latency, sleep
efficiency, and wake after sleep onset). Next, means and standard deviations of each objective
sleep variable and subjective sleep measures (CSHQ and SHS) were computed across participants
(see Table 4 for complete descriptive information).
Objective and subjective sleep patterns also were compared to sleep patterns among
samples of healthy youth from previously published studies (i.e., Meltzer, Walsh, Traylor, &
Westin, 2012; Owens, Spirito, & McGuinn, 2000; Wolfson & Carskadon, 2003) using t-tests.
Compared to normatively developing youth (Owens, Spirito, & McGuinn, 2000), youth with IBD
had significantly greater sleep duration (t = 3.49, p = .002), night wakings (t = 2.71, p = .013), and
daytime sleepiness (t = 8.41, p < .001) as reported on the CSHQ. Regarding actigraphy data,
children and adolescents in the current study experienced significantly lower total sleep duration (t
= - 2.13, p = .043), less wake after sleep onset (t = - 3.18, p = .004), and greater sleep efficiency (t
= 3.04, p = .006) compared to healthy samples (Meltzer, Walsh, Traylor, & Westin, 2012). No
significant differences were demonstrated on the SHS and other CSHQ subscales (see Table 6).
Aim 2.
To examine the associations between sleep patterns, disease activity, and health-related
quality of life, Pearson correlation coefficients were conducted with mean objective sleep
variables, mean subjective sleep variables, mean parent- and child-reported HRQOL (IMPACTIII), and patient age. Pearson correlation coefficients also were calculated using the mean square
successive difference of each of the four objective sleep variables of interest (to assess
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night-to-night instability in sleep patterns), mean parent- and child-reported HRQOL (IMPACTIII), and patient age. The procedure for calculating mean square successive differences involved
subtracting the value of each night (e.g., total sleep time) from the value of the next night and then
squaring the difference for each individual in the study (Jahng, Wood, & Trull, 2008). In addition,
Spearman correlations were conducted with disease activity categories (i.e., “remission,” “mild,”
and “moderate to severe” disease), mean objective sleep variables, mean subjective sleep variables,
and mean square successive differences of objective sleep variables. Moreover, Mann–Whitney U
tests were calculated to determine if there were any significant differences in sleep variables
between participants in a state of disease remission and participants experiencing active disease.
Results revealed that older youth experienced lower objective total sleep duration (r = .502, p = .011). Given this significant finding, partial correlations controlling for patient age were
conducted to examine associations among objective total sleep duration, mean parent- and childreported HRQOL (IMPACT-III), and disease activity categories; however, no significant
associations emerged. Children and adolescents who reported having a higher morning preference
on the SHS morningness/eveningness subscale reported greater HRQOL (r = .485, p = .016).
Youth who experienced greater disease activity had more variable wake after sleep onset as
recorded via actigraphy (ρ= .582, p = .002; U = 2.853, p = .002). All other correlations and group
comparisons were non-significant (see Tables 7 and 8 for full correlation tables).
Aim 3.
Multilevel modeling with restricted maximum likelihood estimation was utilized to analyze
the temporal patterns of objective sleep patterns, abdominal pain, and negative affect across the 14day study period. Separate models were conducted to examine the associations of sleep and pain,
as well as sleep and negative affect. For each model, objective sleep patterns and abdominal pain

33

or negative affect were estimated as the within-person factors. Pain and negative affect scales were
partialed into their overall average and person-centered components. This allows for the “average”
portion to be interpreted similar to an ordinary least square regression as an estimate of betweenperson effects. The person-centered component estimates the deviation from each person’s average
and represents within-person change. Disease activity and patient age were estimated as the
between-persons factors to determine if there are differences in the associations based upon
whether a person is experiencing a symptom flare or is in a period of disease remission and any
differences by age. To examine the hypotheses that youth who report more intense pain and
negative affect during the day will have more objective sleep disturbance at night (hypotheses 3a
and 3c), pain and negative affect variables were estimated to predict sleep that night. In addition,
sleep variables were estimated to predict next-day pain and negative affect in order to determine if
youth who have more objective sleep disturbance report more intense pain or negative affect the
next day (hypotheses 3b and 3d).
Models of abdominal pain predicting sleep onset latency, sleep efficiency, wake after sleep
onset, and total sleep time were designated as models A, B, C, and D, respectively, while the
model of objective sleep variables (i.e., sleep onset latency, sleep efficiency, wake after sleep
onset, and total sleep time) predicting abdominal pain was designated as model E. Additionally,
models of negative affect predicting sleep onset latency, sleep efficiency, wake after sleep onset,
and total sleep time were labeled models F, G, H, and I, respectively, while the model of objective
sleep variables predicting negative affect was labeled model J. For the majority of multilevel
models predicting sleep variables and negative affect or pain (i.e., models B, C, E, F, G, H, I, and
J), a “Hessian” error occurred at the random effects level, indicating that the model was not a
positive definite and did not converge due to lack of variability in the random effects (i.e.,
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individuals do not differ in association of pain or negative affect and sleep). However, removal of
the person-centered components of pain, negative affect, and sleep variables addressed the nonconvergence issue and analyses were conducted without these variables at the random effects level.
The random effects of models B, C, D, G, H, and I demonstrated that there is significant within
person and between person variation in sleep variables to be accounted for in future models (see
Tables 9 and 11 for full model information). The random effects of models E and J also revealed
that there is significant within-person and between-person variation in pain and negative affect,
respectively, to be accounted for in future models (see Tables 10 and 12 for full model
information). There were no significant random effects for any person-centered pain, negative
affect, or sleep variables, indicating that these variables function the same way across individuals.
In terms of fixed effects, patient age was a significant predictor of total sleep time in models D and
I. Specifically, increased age was associated with decreased total sleep time (B = - 12.40, p = .008
for model D; B = - 11.74, p = .013 for model I).
Finally, the association of night-to-night instability in objective sleep patterns, abdominal
pain, and negative affect was examined using multilevel modeling. The square successive
difference of each sleep variable was utilized as a within-persons factor along with abdominal pain
and negative affect, and disease activity and patient age as the between-persons factors. For each
multilevel model predicting night-to-night sleep instability and negative affect or pain, a “Hessian”
error occurred suggesting that the model did not converge and there was not significant change in
sleep instability, pain, or affect scores over time. Removal of person-centered variables and the
intercept from the random effects level did not correct the non-convergence error. Thus, the
multilevel model could not be applied and no further analyses were conducted.
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Aim 4.
The fourth aim was to explore the associations between objective sleep patterns and
positive affect across time. Again, multilevel modeling was utilized to analyze the temporal
patterns of sleep and positive affect across the 14-day study period. Objective sleep patterns and
positive affect were utilized as the within-person factors and disease activity and patient age were
utilized as the between-persons factors for this aim. Similar to Aim 3, positive affect was partialed
into its overall average and person-centered component. Positive affect was estimated to predict
sleep that night and sleep variables were estimated to predict next-day positive affect.
Models of positive affect predicting sleep onset latency, sleep efficiency, wake after sleep
onset, and total sleep time were designated models K, L, M, and N, respectively, while the model
of objective sleep variables (i.e., sleep onset latency, sleep efficiency, wake after sleep onset, and
total sleep time) predicting positive affect was designated model O. For the majority of multilevel
models predicting sleep variables and positive affect (i.e., models L, M, N, and O), a nonconvergence “Hessian” error occurred at the random effects level. However, removal of the
person-centered components of positive affect and sleep variables addressed the non-convergence
issue and analyses were conducted without these variables at the random effects level. The random
effects of models L, M, and N demonstrated that there is significant within person and between
person variation in sleep variables to be accounted for in future models (see Table 13 for full
model information). The random effects of model O also showed that there is significant within
person and between person variation in positive affect to be accounted for in future models (see
Table 14 for full model information). There were no significant random effects for any personcentered positive affect or sleep variables, indicating that these variables function the same way
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across individuals. In terms of fixed effects, increased patient age was associated with decreased
total sleep time in model N (B = - 12.07, p = .015).
In addition, the association between the square successive differences of each objective
sleep variable and positive affect was examined using multilevel modeling. For each multilevel
model predicting night-to-night sleep instability and positive affect, a “Hessian” error occurred
suggesting that the model did not converge and there was not significant change in sleep instability
or affect scores over time. Removal of person-centered variables and the intercept from the random
effects level did not correct the non-convergence error. Thus, the multilevel model could not be
applied and no further analyses were conducted.
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Discussion
The current study had the following aims: 1) to describe objectively measured sleep
patterns and subjective sleep habits among children and adolescents with IBD and compare to
published studies using healthy samples; 2) to examine the associations between subjective sleep
patterns, objective sleep patterns, disease activity, and HRQOL among children and adolescents
with IBD; 3) to examine the associations between objective sleep patterns, abdominal pain, and
negative affect across a 14-day period among children and adolescents with IBD; and 4) to explore
the association between objective sleep patterns and positive affect across a 14-day period among
children and adolescents with IBD. Contrary to hypotheses, no significant associations were
demonstrated among objective sleep variables (i.e., total sleep time, sleep onset latency, wake after
sleep onset, and sleep efficiency), abdominal pain, and negative affect. Additionally, positive affect
was not significantly associated with objective sleep patterns. However, youth in the current study
demonstrated significant differences in subjective and objective sleep compared to data on
normatively developing peers from previously published articles. Associations between sleep
variables and patient age, disease activity, and HRQOL also were exhibited.
Previous research has demonstrated a significant positive association between pain and
sleep difficulties among youth with IBD (Benhayon et al., 2013) and FAP (Haim et al., 2004;
Huntley et al., 2007; Palermo et al., 2007). However, the current study revealed no such
association, which may be due to a number of differences between the current study and previous
literature. First, prior research determined this association by comparing children and adolescents
with IBD or FAP to healthy youth on sleep variables rather than examining the association of sleep
and pain within the illness group. It may be that this association is more pronounced when
comparing different groups rather than comparing within a group. Additionally, the majority of
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previous research utilized samples of youth with FAP rather than pediatric IBD. Pain experienced
by youth with FAP may be a different quality than that of children and adolescents with IBD given
that IBD is characterized by gastrointestinal inflammation unlike FAP (Banez, & Cunningham,
2009). Benhayon and colleagues’ study also is different from the current study in that they utilized
a sample of youth with CD only and subjective sleep measures, while this study included both
pediatric CD and UC and used objective sleep measurement (i.e., actigraphy) to examine the
association of sleep and pain. Therefore, it is possible this previously demonstrated association
might be accounted for by disease group differences or shared method variance.
Another potential explanation for these contradictory findings regarding pain and sleep, as
well as for disease activity and sleep is the lack of variability in disease activity within this sample.
In fact, the majority of patients (80%) were rated by their physicians as being in a state of disease
remission or inactivity. The remaining 20% of participants were rated as experiencing mild disease
activity, while 0% of participants experienced moderate or severe disease activity. This distribution
is in stark contrast to Benhayon and colleagues’ study (2013), in which 68% of participants were
experiencing disease activity. Because periods of disease remission/inactivity are marked by
minimal physical symptoms such as pain (CCFA, 2014), it is possible that participants did not
experience much abdominal pain throughout the study. Indeed, the average pain rating across the
study was 0.93 out of 10 and participants reported pain levels of greater than 1 on only 24% of
diary days. Thus, more variability in disease activity and pain may be necessary to produce
significant associations among these variables and sleep. Future research should aim to include
more heterogeneous samples of pediatric IBD to further elucidate the associations between IBD
symptomatology and sleep disturbance. For example, future studies might employ more specific
inclusion criteria regarding disease activity or pain severity (e.g., include only patients who are
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rated as experiencing a symptom flare). Studies may also consider using ecological momentary
assessment (EMA) to evaluate pain and other variables (e.g., mood) in real time and increase data
variability rather than rely on written diaries where participants potentially complete pain and
mood ratings at the end of the data collection period thereby providing inaccurate ratings
(Shiffman, Stone, & Hufford, 2008).
The lack of relation between affect and sleep also was unexpected given previous research
suggesting an association between sleep and aspects of psychological functioning (e.g., Benhayon
et al., 2013; Palermo et al., 2007). One reason for this finding may be the differences in
measurement of psychological functioning. Prior studies specifically examined measures of
depression and anxiety (e.g., Revised Child Anxiety and Depression Scale in Palermo and
colleagues’ study); however, the current study utilized a more general measure of mood (i.e.,
PANAS-C). It may be that such internalizing symptoms (i.e., depression, anxiety) are more closely
linked with sleep than broad-based negative affect. Although the PANAS-C contains items
assessing aspects of depression (e.g., sad, lonely) and anxiety (e.g., feeling jittery, afraid), the
association of these specific items with sleep may have been reduced by aggregating all negative
affect items into a subscale. Examination of the association of the aforementioned individual items
of the PANAS-C and sleep may have revealed more significant findings. Benhayon and colleagues’
(2013) study also only included youth with comorbid CD and depression, so their results may not
generalize to the current sample, as participants were not screened for depressive symptomatology
and likely did not exhibit significant levels of depressive symptoms. Moreover, the PANAS-C may
not account for the unique psychological issues present within pediatric IBD, including
intrusiveness and anxiety about gastrointestinal symptoms (Banez, & Cunningham, 2009). Instead,
a recently developed measure of gastrointestinal-specific anxiety, the Visceral Sensitivity Index
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(Labus et al., 2004), may better assess the psychological concerns of this population.
Gastrointestinal-specific anxiety might demonstrate a significant association with disrupted sleep
and thus, should be examined in future studies.
While previous research has demonstrated a significant relation between sleep and HRQOL
among various pediatric chronic illness populations (Aviel et al., 2011; Palermo & Kiska, 2005),
this study’s findings did not support previous findings. The absence of a significant association
may be due to differences between disease groups (e.g., symptom characteristics and frequency,
type of treatment and course) because this is the first study to assess the relation between nighttime
sleep and HRQOL within pediatric IBD. However, the current study findings also are inconsistent
with Marcus and colleagues’ (2009) results regarding daytime fatigue and HRQOL. These
conflicting results may be a function of different time frames and administration time points of
study measures. For example, the IMPACT-III and SHS refer to a two-week time period, while the
CSHQ assesses sleep over a one-week time period. The SHS and CSHQ also were administered on
day 1, while the IMPACT-III was administered on day 14 (see Table 1 for study timeline). For
example, it is possible that HRQOL on day 14 is correlated with sleep disruption at day 14, but this
association was not captured by the current study given the different administration points.
Moreover, aggregating the objective sleep variables across the 14-day study period to enable
comparison with the IMPACT-III eliminated the within-person sleep variability and potentially
reduced the association between these variables.
Although some of the study hypotheses were not supported, a few interesting significant
findings emerged. Consistent with Pirinen and colleagues’ study (2010), parents reported that their
children experienced greater sleep disruptions (specifically night wakings and daytime sleepiness)
as compared to healthy youth from previously published studies. In addition, no differences in
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youth-reported sleep disturbance were reported in either study. However, the current study’s results
regarding actigraphic sleep contradict findings of a previous study of adolescents with various
chronic pain conditions (Palermo et al., 2007). More specifically, Palmero and colleagues
determined that adolescents with chronic pain experienced lower sleep efficiency and more night
wakings than normatively developing peers, while the current study found greater sleep efficiency
and less wake after sleep onset when compared to data from published articles using samples of
healthy youth. Inconsistencies in study results may be due to sample differences as the current
study involved a sample of pediatric IBD while Palmero and colleagues utilized a sample of
various chronic pain conditions. Palermo and colleagues’ sample also reported significantly higher
levels of pain (mean usual pain = 6.6 out of 10) than the current sample, which may account for the
differences in findings. Additionally, given the high number of statistical analyses that were
conducted, one cannot discount the possibility that this study’s findings are the result of type I error
and may be spurious.
Furthermore, this study revealed that older youth experienced lower actigraphic total sleep
duration, which conflicts with prior pediatric IBD research (Nachmias et al., 2006) but aligns with
research of normatively developing samples (e.g., Wolfson & Carkadon, 1998). It may be that
differences in measurement of sleep accounted for the discordant findings. Specifically, Nachmias
and colleagues utilized a self-report sleep questionnaire, which may have resulted in inaccurate
estimates of sleep due to social desirability bias or participants being poor historians of their own
sleep. Regarding the association of disease activity and sleep among youth with IBD, mixed results
have been demonstrated with some studies revealing that greater disease activity correlated with
greater sleep disturbance (Benhayon et al., 2013) and others finding no such association (Nachmias
et al., 2006). The current study adds to the literature base by providing additional evidence for the
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potential negative association between sleep and disease activity as increased instability in wake
after sleep onset was demonstrated among youth experiencing more active disease. Lastly,
morningness preference (i.e., preference for completing cognitive and physical activities during the
morning time as opposed to afternoon or evening) was positively associated with better HRQOL.
Randler (2011), who demonstrated similar results among a sample of normatively developing
adolescents, postulated that morningness may serve as a protective factor against a host of
emotional and physical health problems. It may be important for clinicians to screen for
morningness/eveningness preference during routine clinic visits in effort to identify youth with
IBD who are at risk for greater psychosocial issues. However, as mentioned previously, these
results may be influenced by type 1 error and should be interpreted with caution.
The current results should be considered in the light of study limitations. First, the current
sample included children and adolescents spanning a wide age range (i.e., 10-18 years). Although
use of this age range allows for increased generalizability of results, there are drastic changes
regarding sleep patterns that occur between childhood and adolescence. Specifically, decreasing
sleep duration, slow wave sleep, and latency to REM sleep have been correlated with increasing
age among youth (Ohayon, Carskadon, Guilleminault, & Vitiello, 2004). Such differences in sleep
patterns were reflected in this study’s results in that older youth experienced less objective total
sleep time. However, some age-related correlations may have been reduced within the current
study due to the small sample size. Future studies that include a larger sample size of youth with
IBD should be conducted to replicate these results and determine if any additional age-related
associations exist within this population. Although the study’s sample size should provide enough
statistical power to detect medium to large effects based on previous literature that used similar
statistical techniques and examined similar constructs, it is possible the results were impacted by
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type II error and the study was underpowered to detect significant associations. Thus, additional
research using larger sample sizes of youth with IBD may yield hypothesized associations among
sleep, pain, and mood.
The current study also had a number of measurement issues that may have impeded results.
For example, both the SHS and CSHQ demonstrated substandard internal consistency on several
subscales. As a result, it is possible that these questionnaires did not measure the same underlying
construct (i.e., sleep patterns) and impacted the study findings. The low internal consistency of the
CSHQ and SHS subscales may be due to these measures being developed and validated for
different age ranges (i.e., 4-10 years for CSHQ and 13-19 years for SHS) than the current sample
(i.e., 10-18 years). However, the aforementioned measures were chosen because they are both
assess multiple dimensions sleep dysfunction (e.g., daytime sleepiness, sleep/wake schedules),
utilize Likert-type scales that allow for increased response variability (rather than yes/no format of
other measures such as the Pediatric Sleep Questionnaire; Chervin et al., 2000), and assess a
relatively short time period (i.e., 1-2 weeks retrospective report rather than 3-6 months
retrospective report). Although the child version of IMPACT-III has been well validated for use in
pediatric IBD (Otley et al, 2002; Otley et al., 2006), the parent version of this questionnaire has not
been validated. Future studies may want to employ more rigorous psychometric testing of the
parent proxy IMPACT-III as it has demonstrated promising results in terms of reliability (i.e.,
excellent internal consistency within the current study) and concordance with the child version
(Gallo et al., 2014). Moreover, a parent proxy measure of HRQOL may be a desirable clinical tool
if youth have cognitive or other limitations (e.g., too fatigued or ill) that preclude use of a selfreport form (Eiser & Morse, 2001). Finally, actigraphy is not considered the “gold standard” for
sleep assessment. More specifically, actigraphs have demonstrated high sensitivity for identifying
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sleep, but low specificity for identifying wake after sleep onset (Meltzer et al., 2012). It is possible
that actigraphy may not have accurately identified certain aspects of sleep disturbance in the
current study (e.g., wake after sleep onset, sleep efficiency) and impacted study results.
In conclusion, some of the study hypotheses were not supported by the findings. No
significant associations were exhibited for sleep patterns with pain, negative affect, or positive
affect. However, positive associations between disease activity and sleep disturbance, as well as
health-related quality of life and morningness were demonstrated. Moreover, it is encouraging that
children and adolescents who are in disease remission are experiencing good quality sleep and few
emotional problems. This reinforces the importance of psychologists supporting their physician
colleagues in helping youth to manage their IBD and achieve remission status by screening and
providing recommendations to promote adherence to treatment regimens and medical
appointments (Hommel et al., 2013). It also is worth nothing that the current study had several
methodological strengths. This study utilized a multi-method, multi-informant approach including
use of objective sleep data, which is less susceptible to biases associated with subjective
measurement. Use of such an approach lessens the probability of finding significant associations
due to shared method variance. In addition, a prospective study design allows for investigation of
temporal associations between study variables and directionality of these associations. To analyze
these associations, multilevel modeling was utilized. This statistical approach allows for the
examination of data at the within-person level (i.e., changes in an individual across time) and the
between-persons level (i.e., differences between participants), as well as procedures for analyzing
unequal amounts of data and missing data (Curran, Obeidat, & Losardo, 2010). Moreover, because
multilevel modeling draws its statistical power from the number of observations rather than the
number of persons (Curran, Obeidat, & Losardo, 2010; Schwartz & Stone, 1998), use of relatively
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small sample sizes with a large number of observations, like the current study, can have sufficient
statistical power to detect effects. However, it is critical to have diversity in terms of disease
activity and pain severity when utilizing small sample size to ensure there is sufficient variability
among these variables. Future research using longer assessment periods (e.g., three months) and
more valid assessment approaches (e.g., EMA) may capture the waxing and waning course of IBD
symptoms symptomatology (CCFA, 2014) and provide further insight on intra-individual
variability in the association of pain or disease activity and sleep.
Because sleep disruption and circadian rhythm may be associated with gastrointestinal
inflammation (Swanson, Burgess, & Keskavazian, 2011) and inflammatory processes have been
linked to sleep disturbance (Ranjbaran et al., 2007b), it is essential to investigate sleep within
pediatric IBD. This may be especially important among youth with moderate to severe disease
activity, who were not adequately represented in the current sample. It also is necessary to identify
variables that are amendable to intervention (e.g., mood, pain) in efforts to promote sleep in this
population. Future research should continue to assess sleep patterns using multiple subjective and
objective methods, including polysomnography, and potentially associated factors (e.g., GIspecific anxiety, functional disability). Such research may provide insight on how to foster
psychosocial functioning and optimal health outcomes among children and adolescents with IBD.
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Table 1
Study Timeline

a

Time
Time 1
(Day 1)

Patient measures
1) Pain & Sleep Diary
2) Positive and Negative
Affect Schedule for
Children
3) Sleep Habits Survey

Parent measures
1) Family Information
Form
2) Children’s Sleep Habits
Questionnaire

Physician measures
Pediatric Crohn's
Disease Activity Index
or Pediatric Ulcerative
Colitis Activity Index
(depending on patient
diagnosis)

Days 2 –
13a

1) Pain & Sleep Diary
2) Positive and Negative
Affect Schedule for
Children
3) Actigraphy

N/A

N/A

Time 2
(Day 14)

1) Pain & Sleep Diary
2) Positive and Negative
Affect Schedule for
Children
3) Actigraphy
4) IMPACT-III

1) IMPACT-III

N/A

Measures completed daily during this time period
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Table 2
Schedule of Participant Remuneration
Time

Patient remuneration

Parent remuneration

Time 1 (Day 1) measures

$10 gift card

$10 gift card

Days 2 – 13 measures

$2.50 per completed diary
day ($30 for 12 days)
$5 if no missing data

N/A

Time 2 (Day 14) measures

$10 gift card

$10 gift card

Equipment returned

Lottery ticket for 1 of $50
gift cards

N/A
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Table 3
Sample Demographics
Variables (N = 25)

n (%)

Patient age (in years)
Patient gender
Male
Female

14 (56%)
11 (44%)

Patient race
White
Mixed race

22 (88%)
3 (12%)

Diagnosis
Crohn’s disease
ulcerative colitis

20 (80%)
5 (20%)

PCDAI total score
Inactive disease
Mild disease
Moderate to severe disease

17 (68%)
3 (12%)
0 (0%)

PUCAI total score
Disease remission
Mild disease
Moderate to severe disease

3 (12%)
2 (8%)
0 (0%)

Number of symptom flares in past year
0 flares
1 flare
2 flares
3 flares

11 (44%)
8 (32%)
5 (20%)
1 (4%)

Primary caregiver relationship
Mother
Father
Grandmother2
Legal Guardian

22 (88%)
1 (4%)
1 (4%)
1 (4%)

Primary caregiver age (in years)

Mean

SD

Range

14.25

2.42

10 – 18

7.5

7.12

0 – 30

7

9.75

0 – 20

43.36

6.58

34 – 57
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Family structurea
Intact
Blended
Single
Missing

17 (68%)
4 (16%)
3 (12%)
1 (4%)

Mother highest education level
Graduated from high school
Some college or specialized training
Bachelor’s degree
Master’s or doctoral degree

7 (28%)
8 (32%)
9 (36%)
1 (4%)

Father highest education level
7th, 8th, or 9th grade
Graduated from high school
Some college or specialized training
Bachelor’s degree
Master’s or doctoral degree
Missing

1 (4%)
8 (32%)
8 (32%)
4 (16%)
2 (8%)
2 (8%)

Total family income
Less than $10,000
$10,000 – 14, 999
$15,000 – 24,999
$25,000 – 34,999
$35,000 – 49,999
$50,000 – 74,999
$75,000 – 99,999
$100,000 – 149,999
$150,000 or more

1 (4%)
2 (8%)
4 (16%)
2 (8%)
3 (12%)
3 (12%)
5 (20%)
3 (12%)
2 (8%)

a

Intact = married to other biological parent; blended = remarried to step-parent; single = never
been married, divorced, widowed, or living with boyfriend/girlfriend
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Table 4
Descriptives of study variables
Variables
(N = 25, except where noted)
SHS sleepiness scalea

13.13

2.79

Possible Range
(except where noted)
15 – 75

SHS sleep/wake problems behavior scalea

17.96

6.90

10 – 40

SHS Superscience
morningness/eveningness scalea

28.08

4.46

10 – 43

SHS weekday sleep duration (in minutes)a

447.04

70.90

312 – 580e

SHS weekend sleep duration (in minutes)a

572.78

75.58

480 – 737 e

CSHQ total sleep disturbance scoreb

44

4.93

33 – 99

CSHQ bedtime resistanceb

7.39

2.55

6 – 18

CSHQ sleep onset delayb

1.52

0.73

1–3

CSHQ sleep durationb

4.83

1.95

3–9

CSHQ sleep anxietyb

4.91

2.23

4 – 12

CSHQ night wakingsb

4.13

1.10

3–9

CSHQ parasomniasb

7.70

1.52

7 – 21

CSHQ sleep disordered breathingb

3.09

0.60

3–9

13.04

1.94

8 – 24

486.82

50.96

420 – 600 e

11.37

15.74

0 – 60 e

409.81

56.91

326.18 – 514 e

5.65

3.72

0 – 14.73 e

54.36

23.35

9 – 121.15 e

CSHQ daytime sleepinessb
CSHQ sleep duration (in minutes)c
CSHQ night waking duration (in minutes)d
Actigraphy total sleep time (in minutes)
Actigraphy sleep onset latency (in minutes)
Actigraphy wake after sleep onset (in
minutes)

Mean

SD
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85.01%

4.46%

73.93 – 93.34% e

PANAS-C negative affect

19.04

4.21

15 – 75

PANAS-C positive affect

43.81

12.86

15 – 75

0.93

1.24

0 – 10

IMPACT – III youth total score

76.37

11.93

0 – 100

IMPACT – III parent total score

74.71

13.26

0 – 100

Actigraphy sleep efficiency

Average self-report abdominal pain

a

n = 24

b

n = 23

c

n = 22

d

n = 19

e

current sample range
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Table 5
Descriptives of Parental Beliefs and Knowledge Questions
Questions (N = 25)

n (%)

I believe my child gets enough sleep.
Agree
Disagree
Neither agree or disagree

11 (44%)
9 (36%)
5 (20%)

I believe my child has healthy sleep habits.
Agree
Disagree
Neither agree or disagree

9 (36%)
6 (24%)
10 (40%)

Children who don’t get enough sleep are more likely to be
underweight than overweight.
True
False
Don’t know

5 (20%)
11 (44%)
9 (36%)

Snoring in a child indicates that he or she is sleeping well.
True
False
Don’t know

1 (4%)
24 (96%)
0 (0%)

Being either under or over-active can both be warning signs that
a child is not getting enough sleep.
True
False
Don’t know

15 (60%)
4 (16%)
6 (24%)

Watching TV in their bedroom makes it more difficult for
children to fall asleep.
True
False
Don’t know

17 (68%)
4 (16%)
4 (16%)

Children should have the same bedtime and wake time on
weekdays and weekends.
True
False
Don’t know

16 (64%)
7 (28%)
2 (8%)

Children only need a bedtime routine if they are having trouble
falling asleep.
True
False
Don’t know

25 (100%)
0 (0%)
0 (0%)
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Well-rested children don’t need an alarm clock to wake up in the
morning.
True
False
Don’t know

3 (12%)
16 (64%)
6 (24%)

The average preschooler (3-5 years) needs about 10 hours of
sleep/24hrs.
True
False
Don’t know

19 (76%)
3 (12%)
3 (12%)

Being overweight can increase a child’s risk of sleep problems.
True
False
Don’t know

19 (76%)
2 (8%)
4 (16%)

The average school-aged child (6-12 years) needs about 8 hours
of sleep.
True
False
Don’t know

17 (68%)
6 (24%)
2 (8%)
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Table 6
Sleep Variables compared to Healthy Samples
Variable

Current
Study
M(SD)
7.39 (2.55)

Healthy
Comparison
M(SD)
7.06 (1.89)

t

p

df

.62

ns

22

CSHQ sleep onset delaya

1.52 (0.73)

1.25 (0.53)

1.78

ns

22

CSHQ sleep durationa

4.83 (1.95)

3.41 (0.93)

3.49

.002

22

CSHQ sleep anxietya

4.91 (2.23)

4.89 (1.45)

.05

ns

22

CSHQ night wakingsa

4.13 (1.10)

3.51 (0.89)

2.71

.013

22

CSHQ parasomniasa

7.70 (1.52)

8.11 (1.25)

- 1.31

ns

22

CSHQ sleep disordered
breathinga
CSHQ daytime
sleepinessa
SHS sleepinessb

3.09 (0.60)

3.24 (0.63)

- 1.23

ns

22

13.04 (1.94)

9.64 (2.80)

8.41

.001

22

13.13 (2.79)

14.03 (3.51)

- 1.59

ns

23

17.96 (6.90)

18.48 (6.63)

- .37

ns

23

Actigraphy total sleep
time (in minutes)c

409.81
(56.91)

434.10 (60.90)

- 2.13

.043

24

Actigraphy wake after
sleep onset (in minutes) c

54.36
(23.35)

69.20 (40.70)

- 3.18

.004

24

Actigraphy sleep
efficiency

85.01%
(4.46%)

82.30%
(10.30%)

3.04

.006

24

CSHQ bedtime
resistancea

SHS sleep-wake
problemsb

Note: ns = non-significant
a

Healthy comparison data taken from Owens, Spirito, & McGuinn, 2000

b

Healthy comparison data taken from Wolfson & Carskadon, 2003

c

Healthy comparison data taken from Meltzer, Walsh, Traylor, & Westin, 2012
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Table 7
Correlations among Subjective Sleep Variables, Disease Activity, HRQOL, & Patient Age
Variable

IMPACT-III
parenta
- .11

CSHQ bedtime resistance

- .10

.05

- .19

.06

CSHQ sleep onset delay

- .21

- .15

.22

.02

CSHQ sleep duration

- .15

- .28

.22

- .02

CSHQ sleep anxiety

- .17

- .20

- .02

.21

CSHQ night wakings

-. 24

- .35

.15

< .01

CSHQ parasomnias

.06

.12

.23

- .21

CSHQ sleep disordered
breathing

- .12

- .16

.12

.15

CSHQ daytime sleepiness

- .04

.10

- .26

- .08

SHS sleepiness

- .38

- .34

.17

.31

SHS sleep-wake problems

- .14

- . 02

- .03

.12

SHS morningnesseveningness

.49*

.31

- .13

- .20

CSHQ total sleep
disturbance

Disease
Activityb
.21

Patient agea

IMPACT-III
youtha
- .06

- .15

Note: * p < .05, ** p < .01
a

Pearson correlation coefficients

b

Spearman rank correlation coefficients
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Table 8
Correlations among Objective Sleep Variables, Disease Activity, HRQOL, & Patient Age
IMPACT-III
youtha
- .30c

IMPACT-III
parenta
- .10c

Disease
Activityb
.19c

Patient agea

Actigraphy sleep onset
latency

.01

< - .01

.33

- .04

Actigraphy wake after
sleep onset

.05

. 02

.10

- .09

Actigraphy sleep
efficiency

- .03

- .06

- .07

- .19

Actigraphy total sleep
time instability

- .08

.01

.17

.08

Actigraphy sleep onset
latency instability

.15

.16

.15

- .16

Actigraphy wake after
sleep onset instability

- .01

- .01

.58**

< - .01

Actigraphy sleep
efficiency instability

- .02

.13

.17

.07

Variable
Actigraphy total sleep
time

- .50*

Note: * p < .05, ** p < .01
a

Pearson correlation coefficients except where noted

b

Spearman rank correlation coefficients except where noted

c

Partial correlation coefficients controlling for patient age
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Table 9
Multilevel Models of Abdominal Pain Predicting Sleep Variables
Model A: Sleep onset latency
Fixed effects

Β

SE

p

Disease activity – inactive

- 2.81

5.04

ns

Patient age

- .10

.33

ns

Mean pain

- .30

.67

ns

Person-centered pain

2.78

1.32

ns

Intercept

3.09

4.72

ns

Person-centered pain

12.79

13.97

ns

Β

SE

p

Disease activity – inactive

- .24

2.38

ns

Patient age

- .37

.40

ns

Mean pain

.37

.78

ns

Person-centered pain

- .21

.39

ns

18.71

6.75

.006

Random effects

Model B: Sleep efficiency
Fixed effects

Random effects
Intercept

Model C: Wake after sleep onset
Fixed effects

Β

SE

p

Disease activity – inactive

- 2.36

12.63

ns

Patient age

- .80

2.12

ns

Mean pain

- 1.39

4.17

ns

Person-centered pain

- .29

1.44

ns

579.25

190.92

.002

Β

SE

p

- 19.16

25.61

ns

Random effects
Intercept

Model D: Total sleep time
Fixed effects
Disease activity – inactive
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Patient age

- 12.40

4.25

.008

Mean pain

7.85

8.41

ns

Person-centered pain

4.97

6.04

ns

1799.75

785.13

.022

6.17

208.59

ns

Random effects
Intercept
Person-centered pain
Note: ns = non-significant
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Table 10
Multilevel Model of Sleep Variables Predicting Abdominal Pain
Model E: Next day pain
Fixed effects

Β

SE

p

Disease activity – inactive

- .35

.74

ns

Patient age

.10

.14

ns

Mean sleep onset latency

- .04

.13

ns

Mean sleep efficiency

- .07

.25

ns

Mean wake after sleep onset

- .01

.04

ns

Mean total sleep time

.01

.01

ns

Person-centered sleep onset
latency

< - .01

.01

ns

Person-centered sleep
efficiency

< - .01

.02

ns

Person-centered wake after
sleep onset

< .01

< .01

ns

Person-centered total sleep
time

< - .01

< .01

ns

Intercept

1.70

.59

.004

Person-centered sleep
efficiency

< .01

.01

ns

Person-centered total sleep
time

< .01

< .01

ns

Random effects

Note: ns = non-significant
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Table 11
Multilevel Models of Negative Affect Predicting Sleep Variables
Model F: Sleep onset latency
Fixed effects

Β

SE

p

Disease activity – inactive

- 2.45

1.95

ns

Patient age

- .18

.32

ns

Mean negative affect

- .21

.19

ns

Person-centered negative
affect

.15

.17

ns

1.36

4.43

ns

Β

SE

p

Disease activity – inactive

- .60

2.31

ns

Patient age

- .39

.39

ns

Mean negative affect

- .19

.23

ns

.01

.08

ns

17.95

6.49

.006

Random effects
Intercept

Model G: Sleep efficiency
Fixed effects

Person-centered negative
affect
Random effects
Intercept

Model H: Wake after sleep onset
Fixed effects

Β

SE

p

Disease activity – inactive

- .45

12.08

ns

Patient age

- .55

2.05

ns

Mean negative affect

1.49

1.18

ns

Person-centered negative
affect

- .09

.30

ns

535.86

177.16

.002

Random effects
Intercept
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Model I: Total sleep time
Fixed effects

Β

SE

p

Disease activity – inactive

- 21.93

25.74

ns

Patient age

- 11.74

4.32

.013

Mean negative affect

.68

2.52

ns

Person-centered negative
affect

.14

1.24

ns

1874.16

808.05

.020

Random effects
Intercept
Note: ns = non-significant
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Table 12
Multilevel Model of Sleep Variables Predicting Negative Affect
Model J: Next day negative affect
Fixed effects

Β

SE

p

Disease activity – inactive

- 1.51

2.43

ns

Patient age

- .37

.47

ns

Mean sleep onset latency

- .56

.41

ns

Mean sleep efficiency

- .80

.81

ns

Mean wake after sleep onset

- .08

.13

ns

Mean total sleep time

.03

.03

ns

Person-centered sleep onset
latency

.03

.03

ns

Person-centered sleep
efficiency

.06

.08

ns

Person-centered wake after
sleep onset

< .01

.02

ns

Person-centered total sleep
time

< - .01

< .01

ns

17.84

6.49

.006

Random effects
Intercept
Note: ns = non-significant
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Table 13
Multilevel Models of Positive Affect Predicting Sleep Variables
Model K: Sleep onset latency
Fixed effects

Β

SE

p

Disease activity – inactive

- 2.34

1.89

ns

Patient age

- .02

.32

ns

Mean positive affect

- .08

.06

ns

Person-centered positive
affect

.03

.14

ns

Intercept

.72

4.13

ns

Person-centered positive
affect

.12

.17

ns

Β

SE

p

Disease activity – inactive

- .44

2.34

ns

Patient age

- .34

.42

ns

< - .01

.08

ns

- .04

.05

ns

18.42

6.66

.006

Random effects

Model L: Sleep efficiency
Fixed effects

Mean positive affect
Person-centered positive
affect
Random effects
Intercept

Model M: Wake after sleep onset
Fixed effects

Β

SE

p

Disease activity – inactive

- 1.15

12.40

ns

Patient age

- 1.31

2.21

ns

Mean positive affect

- .19

.42

ns

Person-centered positive
affect

.23

.20

ns

Random effects
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Intercept

565.79

186.66

.002

Β

SE

p

Disease activity – inactive

- 22.27

25.82

ns

Patient age

- 12.07

4.56

.015

Mean positive affect

- .06

.86

ns

Person-centered positive
affect

.54

.83

ns

1887.87

811.56

.020

Model N: Total sleep time
Fixed effects

Random effects
Intercept
Note: ns = non-significant
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Table 14
Multilevel Model of Sleep Variables Predicting Positive Affect
Model O: Next day positive affect
Fixed effects

Β

SE

p

Disease activity – inactive

3.77

7.60

ns

Patient age

- 1.81

1.48

ns

Mean sleep onset latency

.87

1.30

ns

Mean sleep efficiency

- .18

2.54

ns

Mean wake after sleep onset

- .09

.41

ns

Mean total sleep time

< .01

.09

ns

Person-centered sleep onset
latency

- .06

.05

ns

Person-centered sleep
efficiency

- .04

.14

ns

Person-centered wake after
sleep onset

.02

.03

ns

Person-centered total sleep
time

< - .01

< .01

ns

186.36

63.46

.003

Person-centered wake after
sleep onset

< .01

< .01

ns

Person-centered total sleep
time

< .01

< .01

ns

Random effects
Intercept

Note: ns = non-significant
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